Intranasal application of S. epidermidis prevents colonization by methicillin-resistant Staphylococcus aureus in mice

Bonggoo Park1, Tadayuki Iwase, George Y Liu

  • 1Division of Infectious Diseases, Department of Pediatrics, Research Division of Immunology, Department of Biomedical Sciences, and the Immunobiology Research Institute, Cedars-Sinai Medical Center, Los Angeles, California, United States of America.

Plos One
|October 15, 2011
PubMed

Insights

Commensal bacteria, like Staphylococcus epidermidis, can prevent nasal colonization by Methicillin-resistant Staphylococcus aureus (MRSA). This suggests using resident bacteria with antibiotics may be a novel strategy against MRSA.

Area of Science:

  • Microbiology
  • Infectious Diseases
  • Bacterial Pathogenesis

Background:

  • Methicillin-resistant Staphylococcus aureus (MRSA) is a significant global health threat, causing widespread infections.
  • Current treatments are insufficient for preventing MRSA colonization, which facilitates infection and transmission.
  • Human nasal flora studies indicate resident bacteria can inhibit Staphylococcus aureus growth.

Purpose of the Study:

  • To investigate whether applying commensal resident bacteria can prevent nasal colonization with MRSA.
  • To explore a novel strategy for combating MRSA colonization and infection.

Main Methods:

  • Development of a murine model to study MRSA nasal colonization.
  • Pre-colonization of mice with the commensal bacterium Staphylococcus epidermidis.
  • Assessment of resistance to subsequent MRSA colonization.

Main Results:

  • Mice pre-colonized with S. epidermidis demonstrated increased resistance to MRSA colonization.
  • This indicates a protective role for commensal bacteria against MRSA nasal colonization.

Conclusions:

  • Application of commensal bacteria, such as S. epidermidis, can prevent MRSA nasal colonization.
  • Combining commensal bacteria with antibiotics may offer a more effective strategy for MRSA prevention.

Related Concept Videos

Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
Staphylococcal Skin Infections01:29

Staphylococcal Skin Infections

Staphylococcus aureus is a Gram-positive coccus that resides harmlessly on the skin and mucous membranes of healthy individuals. When the skin barrier is breached, it can shift from a commensal to an opportunistic pathogen. This transition is facilitated by surface adhesins, such as clumping factor B and S. aureus surface protein G (SasG), which bind to structural proteins, including loricrin and cytokeratin, in the damaged epidermis. Protein A, another key factor, binds the Fc region of...